newsfilter
← Latest News
PR Newswire·

Illumina expands Billion Cell Atlas program with new AI drug developers

Illumina, Inc. (NASDAQ: ILMN) today announced that the Billion Cell Atlas alliance has added three new member companies, including AI-native drug...